Navigation Links
COPD patients can benefit through intense training

Chronic obstructive pulmonary disease(COPD) is a lung disease characterized by difficultly in breathing and the respiratory muscle strength and endurance is often reduced in these patients. Earlier research has shown that high-intensity training is effective in increasing the strength and endurance of respiratory muscles of COPD patients, thereby treating their breathing problems. However, it was found that this intense training// is difficult for the patient, and this has prompted researchers in Perth to conduct a study to see if short, high-intensity training sessions could help COPD patients.

For the study, nine subjects with COPD completed eight weeks of respiratory muscle training combined with a general exercise program. The training included 20-minute sessions, three times a week, where the participant did intense bouts of breathing into a machine. The respiratory strength and endurance were measured during the training period. It was found that just after one week of training the breathing pressures of the participants had improved to 68 per cent of the maximum and by the eighth week, it was 95 per cent of the maximum. The researchers also reported that the respiratory endurance of the participants had also improved. The researchers thus concluded that high-intensity, interval-based training is feasible and effective for patients with COPD.


'"/>




Page: 1

Related medicine news :

1. HIV infected patients can travel safely abroad
2. New vaccine helps allergy and asthma patients
3. Doctors operate upon patients in candlelight- latest from the quake scene
4. New vaccine helps allergy and asthma patients
5. Are cancer patients being taken for a ride?
6. Alternative medicine more popular among HIV positive patients
7. ATG useful in transplant patients as substitute for steroids
8. Antidepressants come in handy for patients on treatment for hepatitis, cancers and multiple sclerosis
9. Distraction therapy found very effective in postoperative patients
10. Cancer patients turning to Internet for information
11. Helping stroke patients to recover balance
Post Your Comments:
(Date:10/7/2008)... WASHINGTON, Oct. 7 /PRNewswire-USNewswire/ -...ight for the second presidential debate, Jean,Berg...e Florida, will be in,the audience, waiting to ask...ts and make it harder for families to afford cover...y 28 years and has never had,healthcare., "It,s t...
(Date:10/7/2008)... Compression ultrasound similar to more expensive... , TUESDAY, Oct. 7 (HealthDay News) -- An o...leg -- called deep vein thrombosis, or DVT -- is a...esearch says. , European researchers found that...alled compression or duplex ultrasound -- was as g...
(Date:10/7/2008)... SEDONA, Ariz., Oct. 7 /PRNewswire/ -- Join M...or a four-day celebration in Sedona,s red rock,cou...Activities include a,series of traditional Native ... Program Director R.J. Joseph and special guest, E...espected Blackfoot Elder from the Blood Reserve,in...
(Date:10/7/2008)... MORE THAN 100,000 PEOPLE ACROSS THE NATION H... CURE(R), DALLAS, Oct. 7 /PRNewswire/ -- To...d all voters about the positions of presidential c... key health care and cancer issues,the Susan G. K...led a,series of resources available on its web sit...
Breaking Medicine News(10 mins):Health News:SEIU Member Will Be in Town Hall Audience, Ready to Ask John McCain Why He Won't Provide Affordable Healthcare for All 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 3Health News:Mii amo Honors Winter Solstice With Traditional Native American Celebration December 18-21 2Health News:Susan G. Komen for the Cure(R) Advocacy Alliance Educates Voters, Debate Watchers on McCain/Obama Health Care Agendas 2Health News:Susan G. Komen for the Cure(R) Advocacy Alliance Educates Voters, Debate Watchers on McCain/Obama Health Care Agendas 3
...l toxins in corn may be the reason for neural tube...the early 1990's. The study published in the on ...gests that corn and its products //that have been ...ht give rise to neural tube defects (NTD), if cons...
...ng is reportedly being prohibited on the grounds o...on a vacation at Utah. The British Medical Journal...second hand smoke (SHS) does not raise the risk //... the measures as attempts by the powerful antismok...
...h officials in Argentina have reported an outbreak...der close to Paraguay. More than 70 cattle have be... province, //according to reports by National Serv... origin of the outbreak is yet to be identified an...
...an Letter, a male nurse aged 27, has admitted to k...hat nothing of what he says could actually justify...eat compassion to alleviate their pain.// He was ...urders to manslaughter, to reduce the penalty. The...
Other Medicine News:Health News:Fungal toxins infected corn the reason for congenital defects 2
(Date:10/7/2008)...of FLEXX Trial Presented at the Osteoarthritis Res... PARSIPPANY, N.J., Oct. 7 /- Ferring...rom the FLEXX Trial of Osteoarthritis of the,Knee,... a highly pure,non-avian high molecular weight for...uperior to intra-articular saline (IA-saline) for ...
(Date:10/7/2008)...nical study of adults, VYVANSE taken once-daily si...ne week, PHILADELPHIA, Oct. 7 /PRNewswire-FirstCa...obal specialty biopharmaceutical company, today,an...sue of the Journal of,Clinical Psychiatry found on...Deficit Hyperactivity Disorder (ADHD) symptoms in ...
(Date:10/7/2008)..., Calif., Oct. 7 /- Aerovance Inc. to...from a Phase I trial of its Aerovant,inhalation po...idence of,local irritancy following asthma patient... dose will be the highest of three doses investiga...hich is scheduled to begin early,next year. Eviden...
(Date:10/7/2008)...5 Patient Cohort Enrolled in Stage A of Trial Asse...h Carboplatin and Paclitaxel -, TUSTIN, Calif., O...uticals, Inc. (Nasdaq: PPHM ), a clinical stage b...ibodies for the treatment of cancer and,hepatitis ...as completed,enrollment in the first stage of a Ph...
Breaking Medicine Technology:Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 2Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 3Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 4Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 2Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 3Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 4Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 5Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 6Data Show Aerovance's Aerovant(TM) Inhalation Powder is Well Tolerated in Asthma Patients 2Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 2Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 3Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 4Young Pop Stars Emphysema Startles Experts 22570 1Young Pop Stars Emphysema Startles Experts 22570 2Young Pop Stars Emphysema Startles Experts 22570 3Studies Show USGI Medicals EndoSurgical Operating System 28TM 29 Enables Incisionless Surgery to Reduce Gastric Pouch and Stoma After Gastric Bypass 6162 1Studies Show USGI Medicals EndoSurgical Operating System 28TM 29 Enables Incisionless Surgery to Reduce Gastric Pouch and Stoma After Gastric Bypass 6162 2Arterial Calcium Scans Can Predict Death Risk 22563 1Arterial Calcium Scans Can Predict Death Risk 22563 2Arterial Calcium Scans Can Predict Death Risk 22563 3Arterial Calcium Scans Can Predict Death Risk 22563 4Advertising Hall of Famer Charles D Peebler Receives Honor for Work Supporting Cure for Progressive Supernuclear Palsy 22559 1Advertising Hall of Famer Charles D Peebler Receives Honor for Work Supporting Cure for Progressive Supernuclear Palsy 22559 2
...LOS ANGELES--(BUSINESS WIRE)--Apr 16, 2007 - Intro...ted ADVEXIN(R) biomarker data over,the weekend in ...he,American Association for Cancer Research., Abno...most,common and fundamental molecular defects in c...o restoring p53 tumor suppressor,function and the ...
...- As previously announced, primary endpoint not me...t-study treatment with ERBITUX,-, NEW YORK, April ... Incorporated and Bristol-Myers Squibb Company tod...- a randomized,open-label, multi-center Phase III...notecan to irinotecan alone in patients with,metas...
Other Medicine Technology:Introgen Presents ADVEXIN Biomarker Data at Major Cancer Conference 2Introgen Presents ADVEXIN Biomarker Data at Major Cancer Conference 3Introgen Presents ADVEXIN Biomarker Data at Major Cancer Conference 4Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 2Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 3Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 4Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 5Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 6Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 7Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 8Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 9
The DLP Elongated One-Piece Arterial Cannulae features a longer body for easier access during conventional and minimally invasive procedures
The Select Series® Arterial Cannulae utilize a state-of-the-art dip-molding technology. This process allows molding of a one-piece, wire-wound cannula that is flexible and kink-resistant.
Intermittent catheter
Intermittent catheter
Medicine Products: